Replay LSI2021 Emerging Medtech Summit

Play Now
innovation hub

Aerpio Therapeutics is Profiled in this Database

Updated At 30 Apr, 2012

Start Free 7 Day Trial Now
Partial description of this company
Novel small molecules and monoclonal antibodies for the treatment of vascular disease and to enhance wound healing, specifically diabetic macular edema and inflammatory bowel disease

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Aerpio Therapeutics plus 4972 other startups.

Start Free 7 Day Trial Now

Learn More About Aerpio Therapeutics

Technology/product details

Revenue projections

Capital raised to date

Growth strategy


Our Clients